relaxin
Animal productexperimental
Relaxin is a protein hormone of about 6000 Da, first described in 1926 by Frederick Hisaw. — Wikipedia
Clinical trial activity
8 trials · 22 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Dec 1, 1991 (NCT00004380)
Timeline
Indications
Mechanism of action
- Prorelaxin H1Supplementation
RLN1 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRelaxin ↗
- NCATS2BD5112J0I ↗
- ChEMBLCHEMBL2107882 ↗
Also known as
- cervilaxin
- relaxin
- relaxin
- relaxin
- relaxin
- releasin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06933602 | N/A | Feb 1, 2025 | Ataturk University |
| NCT03449251 | Phase 2 | Mar 28, 2018 | AstraZeneca, University of Cambridge |
| NCT00520806 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2007 | Corthera, Novartis |
| NCT00406575 | Phase 2 | Nov 1, 2006 | Corthera, Humboldt University |
| NCT00333307 | Phase 1 | Oct 1, 2006 | Corthera, Novartis |
| NCT00259116 | Phase 2 | Nov 1, 2005 | Corthera |
| NCT00704665 | Phase 3 | Dec 1, 1998 | Boston University, Georgetown University, Johns Hopkins University, Medical College of Wisconsin, Medical University of South Carolina, Stanford University, University of California, Los Angeles, University of California, San Diego, University of Chicago, University of Colorado, Denver, University of Connecticut, University of Medicine and Dentistry of New Jersey, University of Pittsburgh, Wayne State University |
| NCT00004380 | Phase 2 | Dec 1, 1991 | National Center for Research Resources (NCRR), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stanford University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (22)
22 organizations
Page 1 / 2